Embecta Corp (NASDAQ: EMBC) on Monday, plunged -4.67% from the previous trading day, before settling in for the closing price of $13.50. Within the past 52 weeks, EMBC’s price has moved between $9.93 and $21.48.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 0.32% over the past five years. The company achieved an average annual earnings per share of 14.73%. With a float of $53.51 million, this company’s outstanding shares have now reached $58.13 million.
Let’s look at the performance matrix of the company that is accounted for 2100 employees. In terms of profitability, gross margin is 63.66%, operating margin of 16.48%, and the pretax margin is 2.64%.
Embecta Corp (EMBC) Insider and Institutional Ownership
Observing investor behavior towards Medical Instruments & Supplies industry stocks is more important than anything else. The insider ownership of Embecta Corp is 7.93%, while institutional ownership is 90.11%. The most recent insider transaction that took place on Feb 25 ’25, was worth 177,646. In this transaction Director of this company bought 13,000 shares at a rate of $13.67, taking the stock ownership to the 76,681 shares. Before that another transaction happened on Feb 13 ’25, when Company’s Director sold 3,100 for $16.38, making the entire transaction worth $50,783. This insider now owns 36,133 shares in total.
Embecta Corp (EMBC) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.79 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 14.73% per share during the next fiscal year.
Embecta Corp (NASDAQ: EMBC) Trading Performance Indicators
Embecta Corp (EMBC) is currently performing well based on its current performance indicators. A quick ratio of 1.67 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.68. Likewise, its price to free cash flow for the trailing twelve months is 25.89.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 1.01, a number that is poised to hit 0.53 in the next quarter and is forecasted to reach 3.02 in one year’s time.
Technical Analysis of Embecta Corp (EMBC)
Embecta Corp (NASDAQ: EMBC) saw its 5-day average volume 0.74 million, a positive change from its year-to-date volume of 0.48 million. As of the previous 9 days, the stock’s Stochastic %D was 8.36%. Additionally, its Average True Range was 0.83.
During the past 100 days, Embecta Corp’s (EMBC) raw stochastic average was set at 4.97%, which indicates a significant increase from 0.76% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 54.38% in the past 14 days, which was lower than the 62.34% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $18.04, while its 200-day Moving Average is $15.46. Nevertheless, the first resistance level for the watch stands at $13.42 in the near term. At $13.98, the stock is likely to face the second major resistance level. The third major resistance level sits at $14.27. If the price goes on to break the first support level at $12.57, it is likely to go to the next support level at $12.28. The third support level lies at $11.72 if the price breaches the second support level.
Embecta Corp (NASDAQ: EMBC) Key Stats
Market capitalization of the company is 748.19 million based on 58,134K outstanding shares. Right now, sales total 1,123 M and income totals 78,300 K. The company made 261,900 K in profit during its latest quarter, and 0 K in sales during its previous quarter.